212 related articles for article (PubMed ID: 28051799)
1. Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis.
Begini P; Gigante E; Antonelli G; Carbonetti F; Iannicelli E; Anania G; Imperatrice B; Pellicelli AM; Fave GD; Marignani M
Ann Hepatol; 2017 Jan-Feb 2017; 16(1):107-114. PubMed ID: 28051799
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
5. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
6. "Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study".
Mardian Y; Yano Y; Ratnasari N; Choridah L; Wasityastuti W; Setyawan NH; Hayashi Y
BMC Gastroenterol; 2019 Dec; 19(1):229. PubMed ID: 31888500
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia impairs prognosis of patients with liver cirrhosis.
Hanai T; Shiraki M; Nishimura K; Ohnishi S; Imai K; Suetsugu A; Takai K; Shimizu M; Moriwaki H
Nutrition; 2015 Jan; 31(1):193-9. PubMed ID: 25441595
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma.
Levolger S; van Vledder MG; Muslem R; Koek M; Niessen WJ; de Man RA; de Bruin RW; Ijzermans JN
J Surg Oncol; 2015 Aug; 112(2):208-13. PubMed ID: 26266324
[TBL] [Abstract][Full Text] [Related]
9. Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients.
Badran H; Elsabaawy MM; Ragab A; Aly RA; Alsebaey A; Sabry A
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3285-3290. PubMed ID: 33247686
[TBL] [Abstract][Full Text] [Related]
10. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
11. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
[TBL] [Abstract][Full Text] [Related]
12. Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.
Akce M; Liu Y; Zakka K; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT; Bilen MA; El-Rayes BF
Am J Clin Oncol; 2021 Feb; 44(2):74-81. PubMed ID: 33350681
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer.
Vashi PG; Gorsuch K; Wan L; Hill D; Block C; Gupta D
PLoS One; 2019; 14(6):e0218761. PubMed ID: 31220163
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
Feng Z; Zhao H; Jiang Y; He Z; Sun X; Rong P; Wang W
Clin Nutr; 2020 Oct; 39(10):3132-3139. PubMed ID: 32057535
[TBL] [Abstract][Full Text] [Related]
15. Impact of Sarcopenia as a Prognostic Factor on Reductive Hepatectomy for Advanced Hepatocellular Carcinoma.
Omiya S; Komatsu S; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Sofue K; Yano Y; Sakai Y; Yanagimoto H; Toyama H; Ajiki T; Fukumoto T
Anticancer Res; 2021 Nov; 41(11):5775-5783. PubMed ID: 34732451
[TBL] [Abstract][Full Text] [Related]
16. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation.
Golse N; Bucur PO; Ciacio O; Pittau G; Sa Cunha A; Adam R; Castaing D; Antonini T; Coilly A; Samuel D; Cherqui D; Vibert E
Liver Transpl; 2017 Feb; 23(2):143-154. PubMed ID: 28061014
[TBL] [Abstract][Full Text] [Related]
17. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.
Montano-Loza AJ; Meza-Junco J; Baracos VE; Prado CM; Ma M; Meeberg G; Beaumont C; Tandon P; Esfandiari N; Sawyer MB; Kneteman N
Liver Transpl; 2014 Jun; 20(6):640-8. PubMed ID: 24678005
[TBL] [Abstract][Full Text] [Related]
18. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
19. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia increases 1-year mortality after surgical resection of hepatocellular carcinoma.
Salman MA; Omar HSE; Mikhail HMS; Tourky M; El-Ghobary M; Elkassar H; Omar MG; Matter M; Elbasiouny AM; Farag AM; Shaaban HE; Atallah M; Elshabacy O; Salman AA
ANZ J Surg; 2020 May; 90(5):781-785. PubMed ID: 31943655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
